Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of detection of trauma-related injuries using combined "all-in-one" fused images and conventionally reconstructed images in acute trauma CT.
Higashigaito K, Fischer G, Jungblut L, Blüthgen C, Schwyzer M, Eberhard M, Dos Santos DP, Baessler B, Vuylsteke P, Soons JAM, Frauenfelder T. Higashigaito K, et al. Among authors: vuylsteke p. Eur Radiol. 2022 Jun;32(6):3903-3911. doi: 10.1007/s00330-021-08473-w. Epub 2022 Jan 12. Eur Radiol. 2022. PMID: 35020010
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: vuylsteke p. Cancer Immunol Immunother. 2024 Dec 30;74(1):32. doi: 10.1007/s00262-024-03873-5. Cancer Immunol Immunother. 2024. PMID: 39738642 Free PMC article. No abstract available.
Treatment approaches for prostate cancer in sub-Saharan Africa.
Kania B, Sharma K, Ramatlho P, Vuylsteke P, Ndlovu A, Mayer T. Kania B, et al. Among authors: vuylsteke p. Transl Cancer Res. 2024 Nov 30;13(11):6503-6510. doi: 10.21037/tcr-23-2289. Epub 2024 Jul 16. Transl Cancer Res. 2024. PMID: 39697741 Free PMC article. Review.
Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana.
Wester JR, Wagner RB, Motladiile B, Nkele I, Chinyepi N, Makhema MJ, Friebel-Klingner TM, Vuylsteke P, Lockman S, Dryden-Peterson S, Kohler RE. Wester JR, et al. Among authors: vuylsteke p. JCO Glob Oncol. 2024 Dec;10:e2400180. doi: 10.1200/GO.24.00180. Epub 2024 Dec 12. JCO Glob Oncol. 2024. PMID: 39666914 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG. De Jaeghere EA, et al. Among authors: vuylsteke p. Gynecol Oncol. 2024 Dec;191:275-286. doi: 10.1016/j.ygyno.2024.10.020. Epub 2024 Nov 7. Gynecol Oncol. 2024. PMID: 39515198 Clinical Trial.
127 results